Curium – uniting IBA Molecular and Mallinckrodt Nuclear Medicine LLC


A world-class radiopharmaceuticals group committed to best-in-class service for customers.


Serving life-saving diagnostic solutions to over 14 million patients annually


Supplying 6,000 private and public hospitals across the globe


A new identity

IBA Molecular and Mallinckrodt Nuclear Medicine LLC proudly unite to become one singular global organisation: Curium.

Our new name is inspired by the pioneering spirit and radiation research performed by Marie and Pierre Curie. It is also a reiteration of our focus on nuclear medicine.

We aim to be a catalyst of Nuclear Medicine industry growth. This means continuously channelling resources and investment into our industry to support its growing role in global healthcare.

Visually, the Curium identity conveys a sense of continuity and advancement along the patient care continuum. Our brand tagline, Life Forward, encapsulates our commitment to customers and the industry we serve.

Together, they demonstrate our dedication to enhancing the quality of health outcomes through patient care, life-saving diagnostics and treatment.

Dedicated to nuclear medicine

We have been dedicated to serving the Nuclear Medicine industry since the 1960s and will continue to build on that proven heritage.

Today, Curium is a world-class provider, with over 100 years of combined experience. We employ over 1,500 people globally and supply more than 6,000 public and private hospitals around the world.

Curium provides potentially life-saving diagnostic solutions to 14 million patients a year—something we are incredibly proud of.

Discover who we are

Advanced Products

Nuclear medicine is essential in monitoring major diseases and makes the provision of reliable life-saving solutions a high priority.

Our products include generators, cold kits and hot products. We also supply auxiliary products to be used in the diagnosis and treatment of various debilitating diseases.

It’s all part of our mission to deliver superior solutions to our clients.

View our products

Unrivalled Production Capabilities

We deliver diagnostic and therapeutic solutions to over 14 million people from a global network of 21 manufacturing centers. These include: 1 Molybdenum facility, 3 large SPECT facilities, 17 PET and 20 SPECT radiopharmacies.

Our main production facilities are located in Saclay, France; Petten in the Netherlands and Maryland Heights, Missouri in the US.

Explore our operations

Latest News
Close x
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
Subscribe to our newsletter

Enter your details to get frequent updates and latest news from Curium.